Literature DB >> 32894333

Ion Channels in Cancer: Orchestrators of Electrical Signaling and Cellular Crosstalk.

Jerry J Fan1,2,3, Xi Huang4,5,6.   

Abstract

Ion channels are pore-forming transmembrane proteins that govern ion flux to regulate a myriad of biological processes in development, physiology, and disease. Across various types of cancer, ion channel expression and activity are often dysregulated. We review the contribution of ion channels to multiple stages of tumorigenesis based on data from in vivo model systems. As intertumoral and intratumoral heterogeneities are major obstacles in developing effective therapies, we provide perspectives on how ion channels in tumor cells and their microenvironment represent targetable vulnerabilities in the areas of tumor-stromal cell interactions, cancer neuroscience, and cancer mechanobiology.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Bioelectrical signaling; Cancer; Ion channels; Mechanobiology; Membrane potential; Metastasis; Tumor heterogeneity; Tumor initiation; Tumor microenvironment; Tumor progression

Mesh:

Substances:

Year:  2022        PMID: 32894333     DOI: 10.1007/112_2020_48

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  113 in total

1.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

2.  Reduced Kv1.3 potassium channel expression in human prostate cancer.

Authors:  Mansoor Abdul; Naseema Hoosein
Journal:  J Membr Biol       Date:  2007-06-02       Impact factor: 1.843

3.  Identification of the gene causing mucolipidosis type IV.

Authors:  R Bargal; N Avidan; E Ben-Asher; Z Olender; M Zeigler; A Frumkin; A Raas-Rothschild; G Glusman; D Lancet; G Bach
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

4.  Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.

Authors:  Etmar Bulk; Anne-Sophie Ay; Mehdi Hammadi; Halima Ouadid-Ahidouch; Sonja Schelhaas; Antje Hascher; Christian Rohde; Nils H Thoennissen; Rainer Wiewrodt; Eva Schmidt; Alessandro Marra; Ludger Hillejan; Andreas H Jacobs; Hans-Ulrich Klein; Martin Dugas; Wolfgang E Berdel; Carsten Müller-Tidow; Albrecht Schwab
Journal:  Int J Cancer       Date:  2015-05-29       Impact factor: 7.396

Review 5.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

6.  DNA methylation of K(v)1.3 potassium channel gene promoter is associated with poorly differentiated breast adenocarcinoma.

Authors:  Marie Brevet; Nathalie Haren; Henri Sevestre; Philippe Merviel; Halima Ouadid-Ahidouch
Journal:  Cell Physiol Biochem       Date:  2009-07-01

Review 7.  Ion channels in development and cancer.

Authors:  Emily Bates
Journal:  Annu Rev Cell Dev Biol       Date:  2015       Impact factor: 13.827

8.  The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.

Authors:  Jasmin R Agarwal; Frank Griesinger; Walter Stühmer; Luis A Pardo
Journal:  Mol Cancer       Date:  2010-01-27       Impact factor: 27.401

9.  Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.

Authors:  Elizabeth Allen; Pascal Miéville; Carmen M Warren; Sadegh Saghafinia; Leanne Li; Mei-Wen Peng; Douglas Hanahan
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

10.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets.

Authors:  Stephen P H Alexander; Eamonn Kelly; Alistair Mathie; John A Peters; Emma L Veale; Jane F Armstrong; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; O Peter Buneman; John A Cidlowski; Arthur Christopoulos; Anthony P Davenport; Doriano Fabbro; Michael Spedding; Jörg Striessnig; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2019-12       Impact factor: 8.739

View more
  2 in total

1.  Characterizing the molecular heterogeneity of clear cell renal cell carcinoma subgroups classified by miRNA expression profile.

Authors:  Tao Shen; Yingdong Song; Xiangting Wang; Haiyang Wang
Journal:  Front Mol Biosci       Date:  2022-08-26

Review 2.  Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy.

Authors:  Anna Choromańska; Agnieszka Chwiłkowska; Julita Kulbacka; Dagmara Baczyńska; Nina Rembiałkowska; Anna Szewczyk; Olga Michel; Agnieszka Gajewska-Naryniecka; Dawid Przystupski; Jolanta Saczko
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.